Cargando…
Microbiota dysbiosis in inflammatory bowel diseases: in silico investigation of the oxygen hypothesis
BACKGROUND: Inflammatory bowel diseases (IBD), which include ulcerative colitis and Crohn’s disease, cause chronic inflammation of the digestive tract in approximately 1.6 million Americans. A signature of IBD is dysbiosis of the gut microbiota marked by a significant reduction of obligate anaerobes...
Autores principales: | Henson, Michael A., Phalak, Poonam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745886/ https://www.ncbi.nlm.nih.gov/pubmed/29282051 http://dx.doi.org/10.1186/s12918-017-0522-1 |
Ejemplares similares
-
Suboptimal community growth mediated through metabolite crossfeeding promotes species diversity in the gut microbiota
por: Henson, Michael A., et al.
Publicado: (2018) -
Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis
por: Yu, Linda Chia-Hui
Publicado: (2018) -
Metabolic Influences of Gut Microbiota Dysbiosis on Inflammatory Bowel Disease
por: Sultan, Salma, et al.
Publicado: (2021) -
The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases
por: Baldelli, Valerio, et al.
Publicado: (2021) -
Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission
por: Pisani, Anthea, et al.
Publicado: (2022)